Status:
WITHDRAWN
Early Diagnosis of Patients With Mild Cognitive Impairment Through the Parameterization of Functional Tests.
Lead Sponsor:
University of Malaga
Collaborating Sponsors:
King's College London
Conditions:
Mild Cognitive Impairment
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
The present study aims to develop an index formed by the variables, functional tests, scales and instruments that best discriminate between healthy subjects and subjects with MCI and that allows the s...
Detailed Description
Dementia affects 46.8 million people and in 2050 it is expected that there will be between 115-135 million people suffering from dementia. Inside dementias, Mild Cognitive Impairment (MCI) has a preva...
Eligibility Criteria
Inclusion
- Subjects over 60 years of age.
- Healthy subjects and subjects diagnosed with mild cognitive impairment.
- Subjects able of filling out questionnaires and performing functional tests.
Exclusion
- Participants with neurological pathologies other than mild cognitive impairment.
- Participation in an experimental study where they receive a treatment.
- Score on the Mini-Mental State Examination of less than 24.
- Inability to get up from the chair at least 5 times or 30 seconds
- Inability to walk 20 meters.
- Inability to raise up both arms to 90 degrees or lifting 2 kg with the hand.
- Inability to walk independently without a walking assistance device (cane, crutch or walker).
- Patients with prescription of beta-blockers.
- Inability to provide informed consent.
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03851198
Start Date
April 1 2020
End Date
September 1 2021
Last Update
December 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Health Science School , University of Malaga
Málaga, Spain, 29009